Header

UZH-Logo

Maintenance Infos

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42


Maddalena, A; Papassotiropoulos, A; Müller-Tillmanns, B; Jung, H H; Hegi, T; Nitsch, R M; Hock, C (2003). Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. Archives of Neurology, 60(9):1202-1206.

Abstract

The diagnostic usefulness of the CSF ratio of phospho-tau to Abeta42 is superior to either measure alone and can be recommended as an aid to evaluating individuals suspected of having dementia.

Abstract

The diagnostic usefulness of the CSF ratio of phospho-tau to Abeta42 is superior to either measure alone and can be recommended as an aid to evaluating individuals suspected of having dementia.

Statistics

Citations

114 citations in Web of Science®
124 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute for Regenerative Medicine (IREM)
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2003
Deposited On:08 Sep 2011 09:01
Last Modified:16 Aug 2016 10:15
Publisher:American Medical Association
ISSN:0003-9942
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1001/archneur.60.9.1202
PubMed ID:12975284

Download

Full text not available from this repository.
View at publisher